PRELUDE CAPITAL MANAGEMENT, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 183 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$280,089
-51.1%
6,990
-28.9%
0.02%
+12.5%
Q2 2022$573,000
+2.1%
9,837
+33.9%
0.02%0.0%
Q1 2022$561,000
-21.2%
7,346
-37.9%
0.02%
-11.1%
Q4 2021$712,000
-12.2%
11,827
-23.4%
0.02%
-60.0%
Q2 2020$811,000
+95.4%
15,447
+24.7%
0.04%
+60.7%
Q1 2020$415,000
+66.0%
12,389
+124.7%
0.03%
+180.0%
Q4 2019$250,000
-24.2%
5,514
-36.4%
0.01%
-33.3%
Q3 2019$330,000
-56.2%
8,674
-49.9%
0.02%
-59.5%
Q2 2019$754,000
+9325.0%
17,327
+8311.2%
0.04%
Q1 2019$8,000
-89.3%
206
-89.7%
0.00%
-100.0%
Q3 2017$75,000
-34.2%
2,000
-20.0%
0.01%
-36.4%
Q1 2017$114,000
-85.6%
2,500
-89.2%
0.01%
-86.7%
Q3 2016$794,000
+1935.9%
23,200
+1928.0%
0.08%
+1560.0%
Q2 2016$39,000
-64.9%
1,144
-45.4%
0.01%
-66.7%
Q1 2016$111,000
-56.6%
2,094
-37.2%
0.02%
-62.5%
Q4 2015$256,000
+848.1%
3,333
+1011.0%
0.04%
+900.0%
Q4 2014$27,000
-87.6%
300
-86.7%
0.00%
-87.1%
Q3 2014$218,000
+2322.2%
2,250
+2150.0%
0.03%
+3000.0%
Q2 2014$9,0001000.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Prosight Management, LP 1,210,377$37,134,36611.77%
Gagnon Advisors, LLC 180,331$5,532,5554.63%
GAGNON SECURITIES LLC 565,429$17,347,3614.35%
ARDSLEY ADVISORY PARTNERS LP 310,000$9,510,8002.12%
RICE HALL JAMES & ASSOCIATES, LLC 968,485$29,713,1201.89%
AlphaCentric Advisors LLC 103,000$3,160,0401.79%
1492 Capital Management LLC 79,687$2,444,7971.58%
ARDSLEY ADVISORY PARTNERS LP 149,000$4,571,3201.02%
OUTFITTER FINANCIAL LLC 32,305$991,1170.93%
Rock Springs Capital Management LP 1,055,500$32,382,7400.87%
View complete list of PACIRA PHARMACEUTICALS INC shareholders